Utility of a Mindfulness App for Outpatients Awaiting Appointments for Mental Health Interventions

Results from the study will provide information on how IMH/SGH and Mobio Interactive(commercial partner) can best provide enhanced healthcare within the outpatient contexton a broader scale. By evaluating the changes in depression and anxiety (amongst othermeasures) in adults and adolescents who are on a waitlist for services at IMH and SGH andreceiving access to AmDTx (compared to placebo control, we can see the effectiveness ofsuch an application in helping patients on future waitlists to decrease their morbiditybefore they see their clinician in the speciaist clinics of IMH and SGH. The study willenable the investigators to evaluate the treatment acceptability, credibility, andsatisfaction of AmDTx and healthcare services at IMH and SGH, as perceived by bothpatients and clinicians, while patients are waitlisted for services and using AmDTx(compared to placebo control). This will enable us to improve the qualtiy of care at bothinstitutions.The study will also allow the investigators to evaluate the association between clinicalsymptom severity and healthcare utilisation with use of AmDTx (compared to placebocontrol), this will futher guide the future triaging of patients to these healthcareinstitutions based on their severity of symptoms as detected with the use of theapplication. This will ensure a more robust and efficient triaging process that catersmore to more sevely unwell patients.